Immunoassays Market Worth $19.1 Billion by 2018

               Immunoassays Market Worth $19.1 Billion by 2018

  PR Newswire

  DALLAS, October 29, 2013

DALLAS, October 29, 2013 /PRNewswire/ --

The "Immunoassay Market  [Technology (Enzyme, Fluorescent,
Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications
(Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users
(Hospitals, Laboratory, Academics)] - Global Forecast to 2018" , provides a
detailed overview of the major drivers, restraints, challenges, opportunities,
current market trends, and strategies impacting the global immunoassays market
along with the estimates and forecasts of the revenue and share analysis.

Browse 118 market data tables with 86 figures spread through 421 pages and
in-depth TOC on "Immunoassay Market [Technology (Enzyme, Fluorescent,
Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications
(Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users
(Hospitals, Laboratory, Academics)] - Global Forecast to 2018".

http://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html

Early buyers will receive 10% customization on this report.

The global Immunoassays Market is segmented by technology, application,
product (analyzers and reagents), and end user. The global Immunoassays
Market, by technology, is further segmented into enzyme immunoassays,
fluorescent immunoassays, chemiluminescence immunoassays, radioimmunoassays,
and others. Enzyme immunoassays accounted for the largest share of the global
immunoassays market in 2012, owing to their long-term presence and high
sensitivity. However, the chemiluminescence Immunoassays Market will see the
highest growth in the next five years, which is attributed to the
high-throughput and automation offered by CLIAs.

On the basis of application, the Immunoassays Market has segments like
oncology, infectious diseases, cardiology, bone and mineral, endocrinology,
autoimmunity, toxicology, hematology (anemia), neonatal screening, and others.
The infectious diseases segment commanded the largest share of 35.2% of the
Immunoassays Market in 2012 due to the high specificity of immunoassays in
diagnosing these diseases. Oncology will be the fastest-growing application
owing to the high prevalence of cancer diseases worldwide and the development
of a wide array of cancer biomarkers.

The Americas is the largest revenue generator for immunoassays, followed by
Europe. Both markets have reached their maturity phase of growth and are
estimated to register mid single-digit growth rates for the next five years.
Asia-Pacific and LATAM are also expected to grow at a rapid pace during the
analysis period owing to the urbanization, huge investment opportunities in
these Immature Markets, and the growing numbers of diagnostic laboratories in
these regions. The growth of the Immunoassays Market will mainly be driven by
countries like China and India that provide a large population base for
companies. Moreover, increasing healthcare spending and government initiatives
will propel the Immunoassays Market in these countries.

The immunoassays segment contributes about one-fourth to the IVD market and is
valued at $13.0 billion in 2013. Immunoassays are characterized by high
specificity, sensitivity, and low costs. It is estimated to be the
second-fastest growing sector of IVD after molecular diagnostics. The
Immunoassays Market will be driven by factors such as growing incidences of
chronic and infectious diseases, increasing aging population, ongoing
technological innovations, increasing demand for non-invasive diagnostic tools
and techniques, and the identification and introduction of novel biomarkers.
The availability of novel tests based on condition-specific markers and
increasing adoption of immunoassay tests in emerging countries are also
factors that exhibit growth opportunities for the Immunoassays Market. There
is also an increasing demand for Lateral flow (LF) tests due to the need for
immediate medical information and the demand for rapid test results, easy and
convenient access, accuracy, and sensitivity. Thus LF tests are driving the
Immunoassays Market.

On the other hand, factors such as the increasing commoditization of certain
immunoassays, stringent regulatory approvals, increasing pricing pressures on
leading players, and reduction in healthcare budget will restrict the growth
of the market.

Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Abbott
Laboratories (U.S.), Danaher Corporation (U.S.), Ortho Clinical Diagnostics
(U.S.), Alere, Inc. (U.S.), Sysmex Corporation (Japan), and DiaSorin S.P.A.
(Italy) are the key industry participants. The Immunoassays Market is
dominated by established players and is consolidated, with the top 5 players
occupying more than 80% of the market. The market offers huge barriers for new
entrants as the industry demands high capital investments for R&D and testing
and manufacturing of products. Moreover, companies have to follow stringent
regulations to get product approvals in various countries.

Browse related reports

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management
Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics,
Haematology) & Applications (Diabetes, Infectious Diseases, Cancer &
Cardiology)] Systems, End Users] - Forecast To 2017

http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html

Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray,
Transcription Mediated Amplification, Hybridization], Applications
Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood
Screening, Microbiology] Global Opportunities, Competitor Analysis & Forecasts
to 2017

http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in
the U.S. We publish strategically analyzed market research reports and serve
as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles,
databases, and custom research services. MarketsandMarkets covers thirteen
industry verticals; including advanced materials, automotives and
transportation, banking and financial services, biotechnology , chemicals,
consumer goods, telecommunications and IT, energy and power, food and
beverages, industrial automation, medical devices,
pharmaceuticals,agriculture industry, semiconductor and electronics,
aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.

Contact: Mr.Rohan North - Dominion Plaza 17304 Preston Road Suite
800,Dallas, TX75252 Tel: +1-888-600-6441 Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @
http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @
http://www.linkedin.com/company/marketsandmarkets
 
Press spacebar to pause and continue. Press esc to stop.